SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
📖

Autoimmune Hypothesis in Alzheimer's Disease

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-hypotheses-autoimmune-hypothesis-al
Related Entities
hypotheses-autoimmune-hypothesis-alzheimers-disease
Metadata
slughypotheses-autoimmune-hypothesis-alzheimers-disease
entity_typehypothesis
kg_node_idNone
Linked Artifacts (549)
mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
related🧪HSP90-Tau Disaggregation Complex Enhancement80%
related🧪VCP-Mediated Autophagy Enhancement80%
related🧪LRP1-Dependent Tau Uptake Disruption80%
related🧪Extracellular Vesicle Biogenesis Modulation80%
related🧪Synaptic Vesicle Tau Capture Inhibition80%
related🧪TREM2-mediated microglial tau clearance enhancement80%
related🧪Trans-Synaptic Adhesion Molecule Modulation80%
related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia80%
related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation80%
related🧪Complement C1QA Spatial Gradient in Cortical Layers80%
related🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation80%
related🧪APOE Isoform Expression Across Glial Subtypes80%
related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro80%
related🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli80%
related🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK80%
related🧪Prefrontal sensory gating circuit restoration via PV interne80%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna80%
related🧪Gamma entrainment therapy to restore hippocampal-cortical sy80%
see_also📖Alzheimer's Disease Biomarkers80%
see_also📖ASL Perfusion Biomarkers for Alzheimer's Disease80%
see_also📖Digital Biomarkers for Alzheimer's Disease80%
see_also📖Dried Blood Spot Biomarker Test for Alzheimer's Disease80%
see_also📖DTI Biomarkers for Alzheimer's Disease80%
see_also📖EEG Biomarkers for Alzheimer's Disease80%
see_also📖Eye-Tracking Digital Markers in Alzheimer's Disease80%
see_also📖Gait Biomarkers for Alzheimer's Disease80%
see_also📖GFAP in Alzheimer's Disease80%
see_also📖Inflammatory Biomarkers in Alzheimer's Disease80%
see_also📖Neurogranin - Alzheimer's Disease Biomarker80%
see_also📖NPTX1 and NPTXR CSF Markers Predict Alzheimer's Disease80%
see_also📖Ocular Fluid Biomarkers for Alzheimer's Disease80%
see_also📖Olfactory Biomarkers for Alzheimer's Disease80%
see_also📖Plasma Phospho-Tau Ratio Diagnostic Panel for Alzheimer'80%
see_also📖Salivary Biomarkers for Alzheimer's Disease80%
see_also📖Sleep Biomarkers for Alzheimer's Disease80%
see_also📖Speech and Cognitive Biomarkers for Alzheimer's Disease80%
see_also📖Synaptic Biomarkers for Alzheimer's Disease80%
see_also📖Tear Film Biomarkers in Alzheimer's Disease80%
see_also📖VILIP-1 and YKL-40 - Alzheimer's Disease Biomarkers80%
see_also📖Diffuse Amyloid Deposits in Alzheimer's Disease80%
see_also📖ACP-204 for Alzheimer's Disease Psychosis (NCT06159673)80%
see_also📖ASN90 Phase 2 Trial - Early Alzheimer's Disease (NCT05680%
see_also📖BIIB080 (MAPTRx) Antisense Oligonucleotide for Alzheimer80%
see_also📖BMS-986368 Phase 2 - Agitation in Alzheimer's Disease80%
see_also📖BMS-986446 Phase 2 Trial for Early Alzheimer's Disease80%
see_also📖Cannabidiol for Alzheimer's Disease Prevention (NCT058280%
see_also📖Centella asiatica Phase 1 Trial for Alzheimer's Disease80%
see_also📖EI-1071 Immunomodulator for Alzheimer's Disease (NCT06780%
see_also📖Escitalopram for Agitation in Alzheimer's Disease (NCT080%
see_also📖ExPlas — Exercise Plasma Transfusion for Alzheimer's Di80%
see_also📖Fasudil for Early Alzheimer's Disease (FEAD) - NCT0636280%
see_also📖[F-18]Flornaptitril PET - Phase 3 for Alzheimer's Disea80%
see_also📖Foralumab Phase 2 Trial for Alzheimer's Disease80%
see_also📖GSK4527226 (AL101) for Early Alzheimer's Disease (NCT0680%
see_also📖Guanfacine NorAD - Phase 3 Trial for Alzheimer's Diseas80%
see_also📖IGC-AD1 for Agitation in Alzheimer's Disease (NCT05543680%
see_also📖ITI-1284 for Alzheimer's Disease Psychosis (NCT0654083380%
see_also📖KarXT (Xanomeline/Trospium) - Phase 3 for Alzheimer's D80%
see_also📖Latrepirdine (DMB-I) Phase 3 Trial for Alzheimer's Dise80%
see_also📖NCT03875638 - Levetiracetam for Alzheimer's Disease80%
see_also📖NCT07477431 - Levetiracetam for Persons at Risk for Alzheime80%
see_also📖LHP588: P. gingivalis Targeting for Alzheimer's Disease80%
see_also📖MAR Polypill for Alzheimer's Disease (NCT06597058)80%
see_also📖Masupirdine for Alzheimer's Disease Agitation80%
see_also📖Masupirdine for Agitation in Alzheimer's Disease (NCT0580%
see_also📖MK-2214 for Early Alzheimer's Disease80%
see_also📖Nabilone for Agitation in Alzheimer's Disease (NCT0451680%
see_also📖NAB-IT: Nabilone for Agitation in Alzheimer's Disease80%
see_also📖TRAILBLAZER-ALZ 3 (NCT05026866) — Donanemab for Preclinical 80%
see_also📖GV1001 for Moderate to Severe Alzheimer's Disease (NCT080%
see_also📖Biogen Alzheimer's Disease Phase 2 Trial (NCT05399888)80%
see_also📖TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Di80%
see_also📖CBD (Cannabidiol) for Alzheimer's Disease Agitation - N80%
see_also📖GSK4527226 (AL101) for Early Alzheimer's Disease (NCT0680%
see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI80%
see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI80%
see_also📖Novartis Alzheimer's Disease Phase 2 Trial (NCT0709451680%
see_also📖NRTIs for Alzheimer's Disease - Phase 1 (NCT07210528)80%
see_also📖X/T + X-EC + Lecanemab Phase 2 (NCT07212062) — Alzheimer80%
see_also📖DMB-I (Latrepirdine) Phase 3 (NCT07251023) — Alzheimer'80%
see_also📖Exciva Alzheimer's Disease Phase 2/3 Trial80%
see_also📖NCT06582706: Nicotinic Acid for Alzheimer's Disease80%
see_also📖NRTIs for Alzheimer's Disease: Targeting Type-I Interfe80%
see_also📖ONO-2020 for Alzheimer's Disease (NCT06881836)80%
see_also📖NCT06803823 - ONO-2020 for Agitation in Alzheimer's Dis80%
see_also📖Ozanimod for Alzheimer's Disease (NCT06862960)80%
see_also📖Piromelatine 20 mg for Mild Dementia Due to Alzheimer's80%
see_also📖PLX5622 CSF1R Inhibitor Trial in Early Alzheimer's Dise80%
see_also📖Probiotics in Mild Alzheimer's Disease (NCT06181513)80%
see_also📖Recombinant Human Serum Albumin for Alzheimer's Disease80%
see_also📖Senicapoc Alzheimer's Disease Trial - NCT0480424180%
see_also📖SHR-1707 for Alzheimer's Disease (NCT06199037)80%
see_also📖Siponimod for Alzheimer's Disease (NCT06639282)80%
see_also📖SNIFF-Combo: Intranasal Insulin + Empagliflozin for Alzheime80%
see_also📖SToP-AD: Suvorexant for Alzheimer's Disease Prevention80%
see_also📖TRAP-AD: Transcranial Photobiomodulation for Alzheimer'80%
see_also📖VY7523 Phase 1/2 Alzheimer's Disease Trial80%
see_also📖Alzheimer's Disease Mechanism Index80%
see_also📖APOE4 and Alzheimer's Disease Risk80%
see_also📖CD33 Siglec Receptor Dysfunction Alzheimer's Disease Ca80%
see_also📖Cholinergic System Degeneration in Alzheimer's Disease80%
see_also📖EEG Microstates in Alzheimer's Disease80%
see_also📖Glymphatic System in Alzheimer's Disease80%
see_also📖Locus Coeruleus Degeneration in Alzheimer's Disease80%
see_also📖Metal Ion Homeostasis in Alzheimer's Disease80%
see_also📖Neuroinflammation in Alzheimer's Disease80%
see_also📖Sex-Specific Mechanisms in Alzheimer's Disease80%
see_also📖Sleep and Circadian Dysfunction in Alzheimer's Disease80%
see_also📖Tau Kinase-Phosphatase Balance in Alzheimer's Disease80%
see_also📖Tau Kinase Signaling Cascade in Alzheimer's Disease80%
see_also📖Ubiquitin-Proteasome System Dysfunction in Alzheimer's 80%
see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh80%
see_also📖EX039 Phase 2 (NCT05413655) — Oral Therapeutic for Alzheimer80%
see_also📖LEAF Trial - THC+CBD for Alzheimer's Disease Agitation 80%
see_also📖Synaptic Therapy Alzheimer's Research Trial (START): A 80%
see_also📖The Alzheimer's Disease Tau Platform Clinical Trial (NC80%
see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St80%
see_also📖Master Screening Study to Determine Individuals With Potenti80%
see_also📖NCT07262645: Near-Infrared Light Therapy for Mild-Moderate A80%
see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime80%
see_also📖APOE Lipid Metabolism Pathway in Alzheimer's Disease80%
see_also📖Endolysosomal Pathway in Alzheimer's Disease80%
see_also📖Geniposide for Alzheimer's disease - immune biomarker t80%
see_also📖Mitochondrial Dysfunction in Alzheimer's Disease Pathwa80%
see_also📖Neuroinflammation Hypothesis in Alzheimer's Disease80%
see_also📖Neurovascular Dysfunction in Alzheimer's Disease: Integ80%
see_also📖NLRP3 Inflammasome Pathway in Alzheimer's Disease80%
see_also📖Sporadic Alzheimer's Disease Pathway80%
see_also📖Synaptic Loss in Alzheimer's Disease Pathway80%
see_also📖Vascular Dementia Mechanisms — Overlap with Alzheimer's80%
related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia72%
related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation72%
related🧪Complement C1QA Spatial Gradient in Cortical Layers72%
related🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation72%
related🧪APOE Isoform Expression Across Glial Subtypes72%
related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro72%
related🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli72%
related🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK72%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal60%
mentions🧪SASP-Driven Aquaporin-4 Dysregulation60%
mentions🧪Aquaporin-4 Polarization Rescue60%
mentions🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors60%
mentions🧫Experiment: Autoimmune Hypothesis Testing in AD60%
related🧫s:** - Test whether HCN1 knockout specifically in EC layer I60%
related🧫Proposed experiment from debate on Synaptic pruning by micro60%
related🧫Brain Connectivity-Targeted tACS Trial in Early AD60%
related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 60%
related🧫4R-Tau Targeting Therapies for PSP and CBS60%
related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi60%
related🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau60%
related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti60%
related🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?60%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap60%
related🧫Anti-Tau Immunotherapy Dosing Optimization60%
related🧫ApoE4 Function in Alzheimer's Disease60%
related🧫Experiment: Autoimmune Hypothesis Testing in AD60%
related🧫Autophagy Enhancement Drug Screening for Neurodegeneration60%
related🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#60%
related🧫Blood-Based Biomarker Panel for Early AD Detection60%
related🧫tACS Connectivity Trial in Early Alzheimer's60%
related🧫Brain Connectivity-Targeted tACS Trial in Early AD60%
related🧫Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 60%
related🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M60%
related🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera60%
related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera60%
related🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa60%
related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation60%
related🧫Gap Junction Dysfunction Validation in Parkinson's Dise60%
related🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas60%
related🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise60%
related🧫Microbiome-Gut-Brain Axis in Alzheimer's Disease — mech60%
related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr60%
related🧫Migraine Cortical Hyperexcitability and Alzheimer's Dis60%
related🧫Mixed Pathology Effects on Parkinson's Disease Progress60%
related🧫Neural Stem Cell Therapy for Alzheimer's Disease60%
related🧫Normal Aging to Alzheimer's Disease Transition Trigger 60%
related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 60%
related🧫Prion Strain Diversity and Selective Vulnerability60%
related🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease60%
related🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#60%
related🧫Sex Differences in Alzheimer's Disease — mechanisms and60%
related🧫Sleep Disruption and Alzheimer's Disease — mechanism an60%
related🧫Traumatic Brain Injury and Alzheimer's Disease Relation60%
related🧫Experiment Validation: In vitro ThT Assay60%
related🧫Tau ASO Therapy60%
related🧫Microglial TREM2 Agonist In Vivo Efficacy60%
related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia60%
related🧫Vascular Contribution to Alzheimer's Disease — Beyond A60%
related🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol60%
related🧫Viral Infections and Alzheimer's Disease — causal mecha60%
see_also📖CARD8 - Caspase Recruitment Domain Family Member 860%
see_also📖CCL4 Gene60%
see_also📖CFB — Complement Factor B60%
see_also📖CR2 (Complement Receptor Type 2)60%
see_also📖IDO1 — Indoleamine 2,3-Dioxygenase 160%
see_also📖IFNAR1 — Interferon Alpha Receptor 160%
see_also📖IRF1 Gene - Interferon Regulatory Factor 160%
see_also📖JUNB Gene60%
see_also📖MOG Gene60%
see_also📖NFAT5 — Nuclear Factor of Activated T Cells 560%
see_also📖NLRP12 — NLR Family Pyrin Domain Containing 1260%
see_also📖NLRP2 — NLR Family Pyrin Domain Containing 260%
see_also📖NLRP6 - NLR Family Pyrin Domain Containing 660%
see_also📖NLRP7 — NLR Family Pyrin Domain Containing 760%
see_also📖npc160%
see_also📖SGK1 Gene60%
see_also📖SOCS3 - Suppressor of Cytokine Signaling 360%
see_also📖TRPM7 Gene60%
see_also📖Packard Center for ALS Research60%
see_also📖Aging vs Neurodegeneration: Mechanistic Comparison Matrix60%
see_also📖Ferroptosis Validation in Parkinson's Disease60%
see_also📖BMP7 Gene (Bone Morphogenetic Protein 7)60%
see_also📖C1S Gene60%
see_also📖CASS2 — CASP2 and RIPK1 Domain Containing Adaptor60%
see_also📖CCL20 Gene60%
see_also📖CD40 - Cluster of Differentiation 4060%
see_also📖FOXP2 Gene60%
see_also📖GATA3 - GATA Binding Protein 360%
see_also📖HSPA1B — Heat Shock Protein 70 Family Member 1B60%
see_also📖IKBKB Gene60%
see_also📖RORA — RAR Related Orphan Receptor A60%
see_also📖SMAD6 — SMAD Family Member 660%
see_also📖Nucleolin Protein60%
see_also📖QRFP Gene60%
see_also📖CALB2 Gene60%
see_also📖CHRNA6 Gene60%
see_also📖CXCR3 Gene60%
see_also📖RAB3B Gene60%
see_also📖RAB3B Protein60%
see_also📖ACSL4 Gene - Acyl-CoA Synthetase Long Chain Family Member 460%
see_also📖CAMKK2 Gene60%
see_also📖NEK7 Gene60%
see_also📖P2RX4 Gene60%
see_also📖SIRT4 Gene60%
see_also📖SIRT7 Gene60%
see_also📖CCR160%
see_also📖DLL4 Gene60%
see_also📖gclc60%
see_also📖HDAC1 Gene60%
see_also📖JAK3 Gene60%
see_also📖RET Gene60%
see_also📖TLR7 Gene60%
see_also📖ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member 160%
see_also📖EPHB3 Gene60%
see_also📖NLR Family Member X160%
see_also📖blarcamesine-axon60%
see_also📖adam1060%
see_also📖NOTCH3 — Notch Receptor 360%
see_also📖SESN1 Gene60%
see_also📖AIM2 Inflammasome Modulation Therapy for Neurodegeneration60%
see_also📖CCL25 Gene60%
see_also📖CCR7 Gene (C-C Chemokine Receptor Type 7)60%
see_also📖CNTF Gene60%
see_also📖cxcr560%
see_also📖DNAJA260%
see_also📖DOCK2 Gene60%
see_also📖GFRAL Gene - GDNF Receptor Alpha Like60%
see_also📖il1rn60%
see_also📖IL7R Gene - Interleukin-7 Receptor Alpha Chain60%
see_also📖IMPDH1 Gene - Inosine Monophosphate Dehydrogenase 160%
see_also📖KMT2D — Lysine Methyltransferase 2D60%
see_also📖LIF — Leukemia Inhibitory Factor60%
see_also📖LRP4 — Low Density Lipoprotein Receptor-Related Protein 460%
see_also📖OGDH — Oxoglutarate Dehydrogenase60%
see_also📖LGI1 Gene60%
related🧪Glymphatic System-Enhanced Antibody Clearance Reversal54%
related🧪SASP-Driven Aquaporin-4 Dysregulation54%
related🧪Aquaporin-4 Polarization Rescue54%
related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors54%
related🧫Experiment: Autoimmune Hypothesis Testing in AD54%
related🧫s:** - Test whether HCN1 knockout specifically in EC layer I54%
related🧫Proposed experiment from debate on Synaptic pruning by micro54%
related🧫Brain Connectivity-Targeted tACS Trial in Early AD54%
related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 54%
related🧫4R-Tau Targeting Therapies for PSP and CBS54%
related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi54%
related🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau54%
related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti54%
related🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?54%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap54%
related🧫Anti-Tau Immunotherapy Dosing Optimization54%
related🧫ApoE4 Function in Alzheimer's Disease54%
related🧫Autophagy Enhancement Drug Screening for Neurodegeneration54%
related🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#54%
related🧫Blood-Based Biomarker Panel for Early AD Detection54%
related🧫tACS Connectivity Trial in Early Alzheimer's54%
related🧫Brain Connectivity-Targeted tACS Trial in Early AD54%
related🧫Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 54%
related🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M54%
related🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera54%
related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera54%
related🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa54%
related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation54%
related🧫Gap Junction Dysfunction Validation in Parkinson's Dise54%
related🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas54%
related🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise54%
related🧫Microbiome-Gut-Brain Axis in Alzheimer's Disease — mech54%
related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr54%
related🧫Migraine Cortical Hyperexcitability and Alzheimer's Dis54%
related🧫Mixed Pathology Effects on Parkinson's Disease Progress54%
related🧫Neural Stem Cell Therapy for Alzheimer's Disease54%
related🧫Normal Aging to Alzheimer's Disease Transition Trigger 54%
related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 54%
related🧫Prion Strain Diversity and Selective Vulnerability54%
related🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease54%
related🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#54%
related🧫Sex Differences in Alzheimer's Disease — mechanisms and54%
related🧫Sleep Disruption and Alzheimer's Disease — mechanism an54%
related🧫Traumatic Brain Injury and Alzheimer's Disease Relation54%
related🧫Experiment Validation: In vitro ThT Assay54%
related🧫Tau ASO Therapy54%
related🧫Microglial TREM2 Agonist In Vivo Efficacy54%
related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia54%
related🧫Vascular Contribution to Alzheimer's Disease — Beyond A54%
related🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol54%
related🧫Viral Infections and Alzheimer's Disease — causal mecha54%
mentions🧪VCP-Mediated Autophagy Enhancement50%
mentions🧪LRP1-Dependent Tau Uptake Disruption50%
mentions🧪Extracellular Vesicle Biogenesis Modulation50%
mentions🧪Prefrontal sensory gating circuit restoration via PV interne50%
mentions🧪Synaptic Vesicle Tau Capture Inhibition50%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%
mentions🧪TREM2-mediated microglial tau clearance enhancement50%
mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy50%
mentions🧪Trans-Synaptic Adhesion Molecule Modulation50%
mentions🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
mentions🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 50%
mentions🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 50%
mentions🧫NPH Glymphatic System Interaction Experiment50%
mentions🧪Oligodendrocyte White Matter Vulnerability50%
mentions🧪Brain Insulin Resistance with Glucose Transporter Dysfunctio50%
mentions🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration50%
mentions🧪Selective HDAC3 Inhibition with Cognitive Enhancement50%
mentions🧪HSP90-Tau Disaggregation Complex Enhancement50%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
mentions🧪CX43 hemichannel engineering enables size-selective mitochon50%
mentions🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu50%
mentions🧪RAB27A-dependent extracellular vesicle engineering for mitoc50%
mentions🧪Liquid-Liquid Phase Separation Modifier Therapy50%
mentions🧪TREM2-Mediated Selective Aggregate Clearance Pathway50%
mentions🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition50%
mentions🧪Senescent Microglia Resolution via Maresins-Senolytics Combi50%
mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%
mentions🧪SASP-Mediated Complement Cascade Amplification50%
mentions🧪Complement C1q Subtype Switching50%
mentions🧪Low Complexity Domain Cross-Linking Inhibition50%
mentions🧪Ocular Immune Privilege Extension50%
mentions🧪Hypocretin-Neurogenesis Coupling Therapy50%
mentions🧪Circadian-Synchronized LRP1 Pathway Activation50%
mentions🧪Mitochondrial Transfer Pathway Enhancement50%
mentions🧪Pharmacological Enhancement of APOE4 Glycosylation50%
mentions🧪Complement-Mediated Synaptic Pruning Dysregulation50%
mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation50%
mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides50%
mentions🧪Senescence-Associated Myelin Lipid Remodeling50%
mentions🧪R-Loop Resolution Enhancement Therapy50%
mentions🧪Reelin-Mediated Cytoskeletal Stabilization Protocol50%
mentions🧪Mechanosensitive Ion Channel Reprogramming50%
mentions🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)50%
mentions🧪Synthetic Biology Rewiring via Orthogonal Receptors50%
mentions🧪Microbial Inflammasome Priming Prevention50%
mentions🧪Phase-Separated Organelle Targeting50%
mentions🧪Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam50%
mentions🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution50%
mentions🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat50%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%
mentions🧪Complement C1QA Spatial Gradient in Cortical Layers50%
mentions🧪Circadian Rhythm Entrainment of Reactive Astrocytes50%
mentions🧪Temporal Decoupling via Circadian Clock Reset50%
mentions🧪Circadian Clock-Autophagy Synchronization50%
mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor50%
mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri50%
mentions🧪Transcriptional Autophagy-Lysosome Coupling50%
mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming50%
mentions🧪Senescence-Induced Lipid Peroxidation Spreading50%
mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue50%
mentions🧪HDAC3-Selective Inhibition for Clock Reset50%
mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization50%
mentions🧪Heat Shock Protein 70 Disaggregase Amplification50%
mentions🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu50%
mentions🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati50%
mentions🧪PARP1 Inhibition Therapy50%
mentions🧪SIRT6-NAD+ Axis Enhancement Therapy50%
mentions🧪Temporal TET2-Mediated Hydroxymethylation Cycling50%
mentions🧪Epigenetic Memory Erasure via TET2 Activation50%
mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬How does metabolic reprogramming (glucose metabolism shifts,50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
related🔬What are the most promising therapeutic strategies for targe50%
related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%
related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration45%
see_also📖Endosomal Sorting Defects in Neurodegeneration45%
see_also📖Gene-Mechanism-Therapy Causal Chains45%
see_also📖Neural Circuit Disruption in Neurodegeneration45%
see_also📖Senescent Cell Clearance in Neurodegeneration45%
see_also📖TREM2 Gene-Mechanism-Therapy Chain — From Genetic Risk to Th45%
mentions🧫Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 44%
mentions🧫Experiment: Multi-Ethnic PD GWAS44%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc40%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
mentions🔬What are the most promising therapeutic strategies for targe40%
mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
related🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration40%
related🧪Selective HDAC3 Inhibition with Cognitive Enhancement40%
related🧪HSP90-Tau Disaggregation Complex Enhancement40%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer40%
related🧪CX43 hemichannel engineering enables size-selective mitochon40%
related🧪VCP-Mediated Autophagy Enhancement40%
related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu40%
related🧪RAB27A-dependent extracellular vesicle engineering for mitoc40%
related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition40%
related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi40%
related🧪Nutrient-Sensing Epigenetic Circuit Reactivation40%
related🧪LRP1-Dependent Tau Uptake Disruption40%
related🧪Extracellular Vesicle Biogenesis Modulation40%
related🧪SASP-Mediated Complement Cascade Amplification40%
related🧪Complement C1q Subtype Switching40%
related🧪Prefrontal sensory gating circuit restoration via PV interne40%
related🧪Low Complexity Domain Cross-Linking Inhibition40%
related🧪Ocular Immune Privilege Extension40%
related🧪Hypocretin-Neurogenesis Coupling Therapy40%
related🧪Synaptic Vesicle Tau Capture Inhibition40%
related🧪Circadian-Synchronized LRP1 Pathway Activation40%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna40%
related🧪Mitochondrial Transfer Pathway Enhancement40%
related🧪Pharmacological Enhancement of APOE4 Glycosylation40%
related🧪Chromatin Accessibility Restoration via BRD4 Modulation40%
related🧪TREM2-mediated microglial tau clearance enhancement40%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides40%
related🧪Senescence-Associated Myelin Lipid Remodeling40%
related🧪Gamma entrainment therapy to restore hippocampal-cortical sy40%
related🧪R-Loop Resolution Enhancement Therapy40%
related🧪Reelin-Mediated Cytoskeletal Stabilization Protocol40%
related🧪Mechanosensitive Ion Channel Reprogramming40%
related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)40%
related🧪Synthetic Biology Rewiring via Orthogonal Receptors40%
related🧪Microbial Inflammasome Priming Prevention40%
related🧪Phase-Separated Organelle Targeting40%
related🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution40%
related🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat40%
related🧪Trans-Synaptic Adhesion Molecule Modulation40%
related🧪Age-Dependent Complement C4b Upregulation Drives Synaptic Vu40%
related🧪Senescence-Induced Lipid Peroxidation Spreading40%
related🧪Hypocretin-Neurogenesis Coupling Therapy40%
related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati40%
related🧪Oligodendrocyte White Matter Vulnerability40%
related🧪SIRT6-NAD+ Axis Enhancement Therapy40%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp36%
mentions🔬What are the mechanisms underlying selective vulnerability o35%
mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp35%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t35%
mentions🔬What are the mechanisms underlying astrocyte reactivity subt35%
mentions🔬What are the mechanisms underlying blood-brain barrier trans35%
mentions🔬What are the mechanisms underlying microglia-astrocyte cross35%
mentions🔬What are the mechanisms underlying apoe4 structural biology 35%
mentions🔬What are the mechanisms underlying digital biomarkers and ai35%
mentions🔬What are the mechanisms underlying senolytic therapy for age35%
mentions🔬What are the mechanisms underlying neuroinflammation resolut35%
mentions🔬What are the mechanisms underlying protein aggregation cross35%
mentions🔬What are the mechanisms underlying sleep disruption as cause35%
mentions🔬What are the mechanisms underlying rna binding protein dysre35%
mentions🔬What are the mechanisms underlying synaptic pruning by micro35%
mentions🔬What are the mechanisms underlying mitochondrial transfer be35%
mentions🔬What are the mechanisms underlying perivascular spaces and g35%
mentions🔬Analyze circuit-level changes in neurodegeneration using All35%
mentions🔬Epigenetic reprogramming in aging neurons35%
mentions🔬Investigate prion-like spreading of tau pathology through co35%
mentions🔬How does metabolic reprogramming (glucose metabolism shifts,35%
SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub